Pharmacovigilance is, in the WHO definition that ICH E2E uses, "the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug related problems."
In practice it is a regulated job. The company that holds a product's approval (the marketing authorization holder, MAH) and the sponsor of a clinical trial must collect safety reports, assess them and send the ones that qualify to regulators such as the FDA and the EMA, by deadlines set in law.
Inside a company the work is shared:
- Drug safety associates (also called case processors) receive reports, check them, enter them in the safety database, code them and assess them.
- Safety physicians review the medical judgment on serious cases.
- Signal analysts look across many cases for new risks.
A drug safety associate does administrative and regulatory work. They never advise a patient about treatment: that belongs to the patient's doctor or pharmacist.
The work of a drug safety team, in one line.